tabish hussain
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
yuichi iida
Faculty of Medicine, Shimane University
Izumo, Japan
Review Editor
Cancer Molecular Targets and Therapeutics
junji itou
National Cerebral and Cardiovascular Center (Japan)
Suita, Japan
Review Editor
Cancer Molecular Targets and Therapeutics
lokesh jain
Merus N.V.
Utrecht, Netherlands
Review Editor
Cancer Molecular Targets and Therapeutics
sonia jain
Mayo Clinic
Rochester, United States
Review Editor
Cancer Molecular Targets and Therapeutics
shadia i jalal
Indiana University Bloomington
Bloomington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
lasse dahl ejby jensen
Linköping University
Linköping, Sweden
Review Editor
Cancer Molecular Targets and Therapeutics
fengyan jin
First Affiliated Hospital of Jilin University
Changchun, China
Review Editor
Cancer Molecular Targets and Therapeutics
haojie jin
Shanghai Cancer Institute
Shanghai, China
Review Editor
Cancer Molecular Targets and Therapeutics
weihua jin
Zhejiang University of Technology
Hangzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
hyuna jo
Seoul National University
Seoul, Republic of Korea
Review Editor
Cancer Molecular Targets and Therapeutics
shirisha jonnalagadda
University of Wisconsin–Whitewater
Whitewater, United States
Review Editor
Cancer Molecular Targets and Therapeutics
cheryl lynn jorcyk
Boise State University
Boise, United States
Review Editor
Cancer Molecular Targets and Therapeutics
justin vareecal joseph
Department of Clinical Medicine, Faculty of Health, Aarhus University
Aarhus, Denmark
Review Editor
Cancer Molecular Targets and Therapeutics
laurie beth joseph
Rutgers, The State University of New Jersey
New Brunswick, United States
Review Editor
Cancer Molecular Targets and Therapeutics
amit kumar
Virginia Commonwealth University
Richmond, United States
Review Editor
Cancer Molecular Targets and Therapeutics